Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “cells”

914 pharma patents match "cells" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 914
Index total 30,257
Page 29 / 39

Quick answer

This filtered view shows 914 pharmaceutical patents matching "cells" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

914 results for “cells” · 30,257 patents in full index Clear search

  1. US 8268618

    Repressing endogenous CCR5 gene expression in cells using engineered zinc finger proteins

    Sangamo Biosciences, Inc. · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted

  2. US 8257932

    Interfacing nanostructures to biological cells

    The Regents of the University of California · Granted Sep 4, 2012 · Expires Aug 30, 2032

    granted

  3. US 8227246

    Compositions of adult disc stem cells for the treatment of degenerative disc disease

    DiscGenics, Inc. · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted

  4. US 8211422

    Chimeric receptor genes and cells transformed therewith

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  5. US 8173123

    Methods of treating colitis involving IL-13 and NK-T cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 8, 2012 · Expires May 3, 2032

    granted

  6. US 8163709

    TAK1-D mediated induction of cell death in human cancer cells by specific sequence short double-stranded RNAS

    The Board of Regents of the University of Texas System · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted

  7. US 8153426

    Preparation of antigen-presenting human gamma-delta T cells and use in immunotherapy

    University College Cardiff Consultants Limited · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted

  8. US 8147845

    Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

    ONCOLYTICS BIOTECH INC. · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted

  9. US 8119398

    Adipose-derived stem cells for tissue regeneration and wound healing

    PrimeGen Biotech LLC · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted

  10. US 8114406

    Peptides and their utility in modulation of behavior of cells expressing α3β1 integrins

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Feb 14, 2012 · Expires Feb 9, 2032

    granted

  11. US 8110554

    Peptides whose uptake by cells is controllable

    The Regents of the University of California · Granted Feb 7, 2012 · Expires Feb 2, 2032

    granted

  12. US 8101159

    In vivo methods of identifying compounds which target suppressed cancer cells

    The Board of Regents of the University of Oklahoma · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted

  13. US 8075921

    Rapamycin-resistant T cells and therapeutic uses thereof

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  14. US 8075920

    Administration of cells and cellular extracts for rejuvenation

    REGENICS AS · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  15. US 8076451

    Selective delivery of molecules into cells or marking of cells in diseased tissue regions using environmentally sensitive transmembrane peptide

    Board of Governors for Higher Education, State of Rhode Island and Providence Plantations · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  16. US 8075881

    Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure

    Regents of the University of Minnesota · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  17. US 8058063

    Method of producing region-specific neurons from human neuronal stem cells

    The Board of Regents of the University of Texas System · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  18. US 8043853

    Postnatal gut neural crest stem cells

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  19. US 8044259

    Determining the capability of a test compound to affect solid tumor stem cells

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  20. US 8034329

    Repair and regeneration of renal tissue using human umbilical cord tissue-derived cells

    Advanced Technologies and Regenerative Medicine, LLC · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted

  21. US 8003091

    Pharmaceutical compositions comprising purified intact bacterial minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Aug 23, 2011 · Expires Aug 18, 2031

    granted

  22. US 7985401

    Peptides whose uptake by cells is controllable

    The Regents of the University of California · Granted Jul 26, 2011 · Expires Jul 21, 2031

    granted

  23. US 7985887

    Regulation of endogenous gene expression in cells using zinc finger proteins

    Sangamo Biosciences, Inc. · Granted Jul 26, 2011 · Expires Jul 21, 2031

    granted

  24. US 7964187

    Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus

    ONCOLYTICS BIOTECH INC. · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.